脱毛症治療薬市場：脱毛症タイプ、性別、投与経路別-2024-2030年の世界予測

脱毛症治療薬市場規模は2023年に12億3,000万米ドルと推計され、2024年には13億7,000万米ドルに達し、CAGR 11.90%で2030年には27億米ドルに達すると予測されます。

脱毛症治療薬の世界市場

脱毛症は、頭皮はじめ体のあらゆる部位の脱毛によって示される病状であり、男女ともに影響を及ぼします。脱毛症治療薬は、さらなる脱毛を予防したり、脱毛した毛髪の再生を促したり、根本的な原因に対処するための薬理学的介入として機能します。例えば、フィナステリドは主に男性の男性型脱毛症の治療に使用され、テストステロンをジヒドロテストステロン（DHT）に変換する酵素である5αリダクターゼを阻害します。一方、ミノキシジルは当初、高血圧の治療薬として開発された血管拡張剤で、男女ともに発毛促進効果が認められています。さらに、免疫シグナル伝達経路に関与するヤヌスキナーゼタンパク質を標的としたJAK阻害剤や、自己血液サンプルからの成長因子を利用した血小板リッチ血漿療法などの新しいアプローチも研究中です。世界の脱毛症治療薬市場は、脱毛の原因となる自己免疫疾患、不健康な生活習慣、運動不足が世界的に急増していることから、大きな成長を遂げています。さらに、数多くのNGOが脱毛症に関する意識向上に積極的に取り組んでおり、市場の成長をさらに後押ししています。しかし、脱毛症治療薬の健康への悪影響や有効性に関する懸念が、市場拡大の抑制要因となっています。さらに、育毛移植や美容治療への嗜好の高まりが、医薬品による介入の採用を妨ぐ可能性もあります。一方、円形脱毛症に対する新規の全身療法に対する規制当局の承認が進みつつあることは、市場参入者にとって有利な機会を提供します。さらに、進行中の円形脱毛症管理の研究開発活動は、将来の進歩に有望な展望をもたらしています。

地域別洞察

南北アメリカでは、円形脱毛症と男性型脱毛症の罹患率の上昇が市場を牽引しています。美的外観を重視する傾向が強まっていることに加え、多様な人口統計プロファイルが、効果的な脱毛治療の必要性を高めています。さらに、大手製薬企業の存在、新規脱毛症治療薬に対するFDA承認の急増、新規治療薬の研究開発への継続的な投資が、この地域の市場開拓を後押ししています。アジア太平洋地域は、様々な脱毛症の有病率の増加と、利用可能な治療オプションに関する患者の意識の高まりにより、脱毛症治療薬産業にとって有望な可能性を示しています。日本、中国、インド、韓国、オーストラリアなどの国々では、都市部の人口がストレスによる脱毛を多く経験しているため、脱毛症治療薬に対するニーズが急増しています。アジア太平洋地域の新興国は、ニーズの高まりに対応するため、皮膚科学と毛髪科学に関連する研究イニシアチブにも資金を提供しています。EMEA（欧州・中東・アフリカ）地域では、医療技術の進歩とともに消費者の嗜好が進化しており、世界の脱毛症治療薬市場は引き続き良好な軌道を維持しています。効果的な治療法に対する消費者の意識の高まりと、ヘルスケア・インフラを改善するための政府の取り組みが、この多様な地域における成長機会を刺激しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは脱毛症治療薬市場を評価する上で極めて重要です。事業戦略や製品満足度に関する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、脱毛症治療薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-脱毛症治療薬市場の市場規模および予測は？

2-脱毛症治療薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-脱毛症治療薬市場における技術動向と規制の枠組みは？

4-脱毛症治療薬市場における主要ベンダーの市場シェアは？

5-脱毛症治療薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で自己免疫疾患の有病率が増加
    • 不健康なライフスタイルや身体活動の不足が急増
    • 脱毛症の状態についての認識を高めるNGOの数が増加
  • 抑制要因
    • 脱毛症治療薬の健康への悪影響と薬の有効性に関する懸念
  • 機会
    • 円形脱毛症の新しい全身治療薬に対する新たな規制当局の承認
    • 脱毛症治療のための調査開発活動を加速
  • 課題
    • 育毛移植や美容治療の希望が急増
• 市場セグメンテーション分析
• 市場動向分析
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み

第6章 脱毛症治療薬市場：脱毛症タイプ別

• 円形脱毛症
• 全頭脱毛症
• 汎発性脱毛症

第7章 脱毛症治療薬市場：性別別

• 男性
• 女性

第8章 脱毛症治療薬市場：投与経路別

• 注射可能
• 経口
• 局所

第9章 南北アメリカの脱毛症治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の脱毛症治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの脱毛症治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ主要企業別の分析
  • 合併・買収
  • 受賞・表彰・拡大

第13章 競争力のあるポートフォリオ

• 主要な企業プロファイル
  • AndroScience Corporation
  • Capillus, LLC by Curallux, LLC
  • Cipla Inc.
  • Concert Pharmaceuticals, Inc.
  • Daiichi Sankyo Company, Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Hairline Co.
  • Merck & Co., Inc.
  • The Himalaya Drug Company
  • Vitabiotics Ltd.
• 主要な製品ポートフォリオ

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. ALOPECIA DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. ALOPECIA DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. ALOPECIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ALOPECIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. ALOPECIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ALOPECIA DRUGS MARKET DYNAMICS
• FIGURE 7. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2023 VS 2030 (%)
• FIGURE 8. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
• FIGURE 10. ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 12. ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ALOPECIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 22. ALOPECIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. ALOPECIA DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. ALOPECIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 6. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 10. ALOPECIA DRUGS MARKET SIZE, BY MEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ALOPECIA DRUGS MARKET SIZE, BY WOMEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 13. ALOPECIA DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. ALOPECIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. ALOPECIA DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 26. CANADA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 27. CANADA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. CHINA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 44. CHINA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 46. INDIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 47. INDIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 98. ITALY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 99. ITALY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 110. POLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 111. POLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 113. QATAR ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 114. QATAR ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 143. ALOPECIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 144. ALOPECIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. ALOPECIA DRUGS MARKET LICENSE & PRICING

[187 Pages Report] The Alopecia Drugs Market size was estimated at USD 1.23 billion in 2023 and expected to reach USD 1.37 billion in 2024, at a CAGR 11.90% to reach USD 2.70 billion by 2030.

Global Alopecia Drugs Market

Alopecia is a medical condition indicated by hair loss from the scalp or other body parts, affecting both males and females. Alopecia drugs serve as pharmacological interventions to prevent further hair loss, stimulate the regrowth of lost hair or address underlying causes. For instance, Finasteride is primarily utilized for treating androgenetic alopecia in men by inhibiting the enzyme 5-alpha-reductase responsible for converting testosterone into dihydrotestosterone (DHT) - a hormone linked to male pattern baldness. On the other hand, Minoxidil is a vasodilator initially developed to treat hypertension that has been approved for promoting hair growth in both sexes. Moreover, novel approaches, such as JAK inhibitors targeting Janus kinase proteins involved in immune signaling pathways or Platelet-Rich Plasma therapy harnessing growth factors from autologous blood samples, are under investigation. The global alopecia drugs market is experiencing significant growth due to the worldwide surging prevalence of autoimmune diseases, unhealthy lifestyle habits, and physical inactivity contributing to hair loss. Furthermore, numerous NGOs are actively working to raise awareness about alopecia, further fueling market growth. However, concerns about alopecia drugs' adverse health impacts and efficacy act as restraining factors for the market's expansion. Additionally, a surge in preference for hair growth transplants and cosmetic treatments may hinder the adoption of pharmaceutical interventions. On the other hand, emerging regulatory approvals for novel systemic therapies for alopecia areata offer lucrative opportunities for market players. Additionally, ongoing research and development activities in alopecia management bring promising prospects for future advancements.

Regional Insights

In the Americas, the market is primarily driven by a rising incidence of alopecia areata and male-pattern baldness. The increasing emphasis on aesthetic appearances combined with a diverse demographic profile contributes to the need for effective hair loss treatments. Moreover, the presence of leading pharmaceutical companies, surging FDA approvals for novel alopecia treatments, and continuous investments in research and development for novel therapies have bolstered market growth in this region. The APAC shows promising potential for the alopecia drug industry due to the increased prevalence of various hair loss disorders and growing patient awareness about available treatment options. Countries such as Japan, China, India, South Korea, and Australia are experiencing an upsurge in the need for alopecia drugs as their urban population experiences higher levels of stress-induced hair loss. Emerging economies in the APAC region are also funding research initiatives related to dermatology and trichology to meet growing needs. In the EMEA region, evolving consumer preferences alongside advances in medical technology continue to foster positive trajectories within the global alopecia drug market. Rising consumer awareness about effective treatments and government initiatives to improve healthcare infrastructure has stimulated growth opportunities within this diverse territory.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alopecia Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alopecia Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Drugs Market, highlighting leading vendors and their innovative profiles. These include AndroScience Corporation, Capillus, LLC by Curallux, LLC, Cipla Inc., Concert Pharmaceuticals, Inc., Daiichi Sankyo Company, Ltd., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Hairline Co., Merck & Co., Inc., The Himalaya Drug Company, and Vitabiotics Ltd..

Market Segmentation & Coverage

This research report categorizes the Alopecia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Alopecia Types
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
• Gender
  • Men
  • Women
• Route of Administration
  • Injectable
  • Oral
  • Topical
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Alopecia Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alopecia Drugs Market?

3. What are the technology trends and regulatory frameworks in the Alopecia Drugs Market?

4. What is the market share of the leading vendors in the Alopecia Drugs Market?

5. Which modes and strategic moves are suitable for entering the Alopecia Drugs Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Alopecia Drugs Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of autoimmune diseases across the globe
    • 5.1.1.2. Surging adoption of unhealthy lifestyles and physical inactivity
    • 5.1.1.3. Increasing number of NGOs to create awareness about alopecia condition
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse health impact of alopecia drugs and concern with drugs efficacy
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging regulatory approvals for the novel systemic treatment for alopecia areata
    • 5.1.3.2. Accelerating research and developments activities for alopecia management
  • 5.1.4. Challenges
    • 5.1.4.1. Surge in preference for the hair growth transplant and cosmetic treatment
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Alopecia Drugs Market, by Alopecia Types

• 6.1. Introduction
• 6.2. Alopecia Areata
• 6.3. Alopecia Totalis
• 6.4. Alopecia Universalis

7. Alopecia Drugs Market, by Gender

• 7.1. Introduction
• 7.2. Men
• 7.3. Women

8. Alopecia Drugs Market, by Route of Administration

• 8.1. Introduction
• 8.2. Injectable
• 8.3. Oral
• 8.4. Topical

9. Americas Alopecia Drugs Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Alopecia Drugs Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Alopecia Drugs Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player
  • 12.3.1. Merger & Acquisition
    • 12.3.1.1. Sun Pharma to acquire US-based Concert Pharmaceuticals for USD 576 million
  • 12.3.2. Award, Recognition, & Expansion
    • 12.3.2.1. FDA Approves Pfizer's Alopecia Drug
    • 12.3.2.2. FDA Approves Lilly and Incyte's OLUMIANT (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata

13. Competitive Portfolio

• 13.1. Key Company Profiles
  • 13.1.1. AndroScience Corporation
  • 13.1.2. Capillus, LLC by Curallux, LLC
  • 13.1.3. Cipla Inc.
  • 13.1.4. Concert Pharmaceuticals, Inc.
  • 13.1.5. Daiichi Sankyo Company, Ltd.
  • 13.1.6. Dr. Reddy's Laboratories Ltd.
  • 13.1.7. Eli Lilly and Company
  • 13.1.8. Hairline Co.
  • 13.1.9. Merck & Co., Inc.
  • 13.1.10. The Himalaya Drug Company
  • 13.1.11. Vitabiotics Ltd.
• 13.2. Key Product Portfolio

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing